首页> 外文期刊>Journal of Medicinal Chemistry >Small-molecule ligands of methyl-lysine binding proteins
【24h】

Small-molecule ligands of methyl-lysine binding proteins

机译:甲基赖氨酸结合蛋白的小分子配体

获取原文
获取原文并翻译 | 示例
           

摘要

Proteins which bind methylated lysines ("readers" of the histone code) are important components in the epigenetic regulation of gene expression and can also modulate other proteins that contain methyl-lysine such as p53 and Rb. Recognition of methyl-lysine marks by MBT domains leads to compaction of chromatin and a repressed transcriptional state. Antagonists of MBT domains would serve as probes to interrogate the functional role of these proteins and initiate the chemical biology of methyl-lysine readers as a target class. Small-molecule MBT antagonists were designed based on the structure of histone peptide-MBT complexes and their interaction with MBT domains determined using a chemiluminescent assay and ITC. The ligands discovered antagonize native histone peptide binding, exhibiting 5-fold stronger binding affinity to L3MBTL1 than its preferred histone peptide. The first cocrystal structure of a small molecule bound to L3MBTL1 was determined and provides new insights into binding requirements for further ligand design.
机译:结合甲基化赖氨酸的蛋白质(组蛋白代码的“阅读器”)是基因表达的表观遗传调控中的重要组成部分,并且还可以调节其他含有甲基赖氨酸的蛋白质,例如p53和Rb。 MBT结构域对甲基赖氨酸标记的识别导致染色质的紧缩和转录状态的抑制。 MBT结构域的拮抗剂将充当探针来询问这些蛋白质的功能,并启动甲基赖氨酸阅读器的化学生物学作为目标类别。基于组蛋白肽-MBT复合物的结构及其与MBT结构域的相互作用,设计小分子MBT拮抗剂,使用化学发光分析和ITC进行测定。发现的配体拮抗天然组蛋白肽的结合,对L3MBTL1的结合亲和力是其优选组蛋白肽的5倍。确定了与L3MBTL1结合的小分子的第一个共晶体结构,并为进一步的配体设计提供了结合要求的新见识。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号